While we can mathematically quantify the corresponding risk to laboratory workers, extending that risk assessment to the local and global community poses numerous challenges. First, we need a full ...
TheFly reported on April 7 that Citigroup lowered its rating on BIO from Buy to Neutral and reduced its price target from ...
The process of discovering a new drug has historically been agonisingly slow and tremendously expensive. In recent years, artificial intelligence has promised to drastically accelerate this timeline ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results